📰 Rapid Vertical News
Rapid Vertical News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rapid Vertical. Real-time updates on events, politics, business and more.
March 13, 2024
HALIFAX, NS / ACCESSWIRE / March 13, 2024 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of a Canadian patent patent (number 2,949,634) for its new innovative and quantitative test system. This is in addition to the U.S. patent (number 11,353,450) received in 2022. Through this new patent, MedMira...
February 21, 2023
PROVIDENCE, R.I. & HALIFAX, Nova Scotia--(BUSINESS WIRE)--#HIV--Maternova, Inc., accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira Inc. (TSXV: MIR), a developer and manufacturer of rapid diagnostics, today announced that the companies have entered into a multin...
February 20, 2023
HALIFAX, NS / ACCESSWIRE / February 20, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the singing of a multinational distribution agreement with ?Maternova, Inc., Rhode Island, USA. ?Maternova
January 11, 2023
HALIFAX, NS / ACCESSWIRE / January 11, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of the CE mark for its VYRA CoV2Flu Antigen Test (VYRA CoV2Flu), the fastest combination antigen
January 4, 2023
HALIFAX, NS / ACCESSWIRE / January 3, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the publication of Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually
December 30, 2022
HALIFAX, NS / ACCESSWIRE / December 29, 2022 / Today, MedMira Inc. (MedMira) (TSXV:MIR) presents its latest addition to the VYRATM product line, the VYRATM TriDemic Antigen Rapid Test for the simultaneous
October 14, 2022
HALIFAX, NS / ACCESSWIRE / October 14, 2022 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of the CE mark for its VYRA COVID-19 Antigen Test (VYRA COVID-19), the fastest SARS-CoV-2 Antigen
May 27, 2022
HALIFAX, Nova Scotia, May 27, 2022 -- Today, MedMira Inc. provides an update on its regulatory progress in Europe and any market accepting the CE mark. MedMira has received the CE mark for three... | May 27, 2022
May 20, 2022
HALIFAX, Nova Scotia, May 20, 2022 -- Today, MedMira Inc. provides an update on the Company’s regulatory work for Canada for its VYRA™ product line. On the 10th of May 2022,... | May 20, 2022
May 12, 2022
HALIFAX, Nova Scotia, May 12, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its...